- Report
- November 2021
Canada, Mexico, North America Canada, Mexico, North America
From €8646EUR$9,500USD£7,412GBP
- Report
- November 2021
Middle East
From €8646EUR$9,500USD£7,412GBP
- Report
- November 2021
Latin America
From €13196EUR$14,500USD£11,313GBP
- Report
- November 2021
Europe
From €22297EUR$24,500USD£19,115GBP
- Report
- November 2021
Asia Pacific
From €13196EUR$14,500USD£11,313GBP
- Report
- November 2021
Global
From €31398EUR$34,500USD£26,918GBP
The Plasminogen Activator market is a subset of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Plasminogen Activators are a type of drug used to treat thrombolytic disorders, which are conditions that involve the formation of blood clots. These drugs work by activating plasminogen, an enzyme that helps dissolve blood clots. Plasminogen Activators are used to treat a variety of conditions, including deep vein thrombosis, pulmonary embolism, and stroke.
The Plasminogen Activator market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Bayer, Sanofi, and Boehringer Ingelheim. Other companies in the market include Bristol-Myers Squibb, Merck, and Novo Nordisk. Show Less Read more